Nicholas Kenyon

Nick Kenyon is an associate director and MPI of the UC Davis Clinical and Translational Science Center, director of the CTSC Workforce Development for Investigators program, and director of the ICorps@NCATS program at UC Davis. A graduate of the CTSC Mentored Clinical Research Training Program and prolific collaborator on innovative research and development projects, Kenyon was also the recipient of a career development award to study the effects of nitric oxide in models of airway inflammation and this work translated into an FDA new drug application and clinical trial to study L-arginine in adult severe asthma. He is the co-principal investigator on an NCATS U18 RADx SCENT (Kenyon, Davis) proposal to define breath signatures of COVID-19 and bring breath sensors to market.

Kenyon is professor and division chief of Pulmonary, Critical Care, and Sleep Medicine. His clinical interests focus on asthma, chronic obstructive pulmonary disease (COPD), environmental health, non-invasive markers of airway disease and critical care. His research interests are in airway diseases and lung injury. As a physician-scientist and co-director of the UC Davis Asthma Network (UCAN) clinics with a research interest in adult severe asthma, he and his laboratory staff and are working to develop the next medications to improve the care of all patients with severe asthma.